Pediatric cancer stem cell identified: understanding the origin of ERMS

May 17, 2007

As published in the June 1 issue of Genes & Development, Dr. Leonard Zon (Children’s Hospital Boston) and colleagues have identified the cancer stem cell for rhabdomyosarcoma, the most common soft-tissue sarcoma of childhood.

“Identifying the cancer stem cell and the evolutionarily conserved genetic programs underlying self-renewal in ERMS will likely lead to new insights into how to destroy these cell types in established malignancies,” explains Dr. Zon.

Rhabdomyosarcoma (RMS) is an aggressive cancer that arises from a primitive skeletal muscle cell called a "rhabdomyoblast". Depending upon on the histology of the cancerous cells, there are several different subtypes of RMS. Embryonal rhabdomyosarcoma (ERMS) is the most common subtype, usually found in children under 15, in the head and neck region and genitourinary tract.

Dr. Zon and colleagues have developed an animal model to identify and test therapeutic targets of human ERMS. The scientists artificially activated the RAS pathways to induce ERMS in a strain of genetically engineered zebrafish. Some transgenic zebrafish developed visible tumors by 10 days of age.

Through their model, Dr. Zon and colleagues were able to identify both an ERMS tumor-cell-of-origin and a novel genetic signature that underlies ERMS progression in zebrafish and human patients. Cancer stem cells make up only a small fraction of the overall number of cells in a tumor. However, they are capable of giving rise to other cancer cells, and thereby drive tumor growth and metastasis. To prevent recurrence and progression, effective long-term therapies must target the self-renewing population of cancer stem cells.

“The zebrafish is ideally suited for use in targeted chemical genetic approaches to specifically inactivate cancer pathways we have identified in our study. Identifying drugs that inactivate these pathways in the ERMS cancer stem cell may have far reaching implications for treatment of patients with this disease.”

Source: Cold Spring Harbor Laboratory

Explore further: Congressional action needed to optimize regulation of genomic tests

Related Stories

The monopoly of aluminium is broken

6 hours ago

Discovering Majorana's was only the first step, but utilizing it as a quantum bit (qubit) still remains a major challenge. An important step towards this goal has just been taken, as shown by researchers ...

Yik Yak's frat-bro founders shrug off growing pains

6 hours ago

The most popular post of all time on Yik Yak is a dirty joke. Less than 2 years old, the Atlanta-based social network is geared mostly toward college students who access and post unsigned announcements through an app on their ...

Fears for pink iguanas as Galapagos volcano erupts

6 hours ago

A volcano in the Galapagos islands erupted for the first time in more than 30 years Monday, sending streams of lava flowing down its slopes and potentially threatening the world's only colony of pink iguanas.

Recommended for you

A new era for genetic interpretation

16 hours ago

Millions of genetic variants have been discovered over the last 25 years, but interpreting the clinical impact of the differences in a person's genome remains a major bottleneck in genomic medicine. In a paper published in ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.